Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2 - Chao Su; Juanhua He; Yufeng Xie; Yu Hu; Xin Li; Shitong Qiao; Peipei Liu; Min Huang; Rong Zhang; Liang Wang; Zhen Chang; Wenqiao Sun; et al. (hLife, 2025)